What does USPSTF recommend for women with family history of breast, ovarian, tubal, or peritoneal cancer?

What does USPSTF recommend for women with family history of breast, ovarian, tubal, or peritoneal cancer?

• A. Immediate BRCA testing
• B. No screening needed
• C. Population-based screening only
• D. Use familial risk stratification tools and referral for genetic counseling if positive

Answer: (D)

This item tests how USPSTF advises handling genetic risk for breast/ovarian cancer in women with a family history. The recommended approach is to first use validated familial risk assessment tools to identify those at increased risk, and then refer for genetic counseling if the risk is elevated. From there, testing is considered based on the counseled discussion and individual risk, rather than testing everyone with a family history or skipping screening entirely. Using familial risk stratification tools helps focus resources on those most likely to have a BRCA1/BRCA2 mutation, balancing benefits and harms of testing. Genetic counseling provides education about what a positive result means, potential management options (such as enhanced surveillance or risk-reducing strategies), and implications for family members. Immediate testing for all with a family history or population-based screening of all women is not recommended because many with a family history do not carry a pathogenic mutation, and universal testing can lead to unnecessary anxiety, false positives, and increased costs.

This item tests how USPSTF advises handling genetic risk for breast/ovarian cancer in women with a family history. The recommended approach is to first use validated familial risk assessment tools to identify those at increased risk, and then refer for genetic counseling if the risk is elevated. From there, testing is considered based on the counseled discussion and individual risk, rather than testing everyone with a family history or skipping screening entirely.

Using familial risk stratification tools helps focus resources on those most likely to have a BRCA1/BRCA2 mutation, balancing benefits and harms of testing. Genetic counseling provides education about what a positive result means, potential management options (such as enhanced surveillance or risk-reducing strategies), and implications for family members. Immediate testing for all with a family history or population-based screening of all women is not recommended because many with a family history do not carry a pathogenic mutation, and universal testing can lead to unnecessary anxiety, false positives, and increased costs.